J
John Walsh
Researcher at University of Michigan
Publications - 5
Citations - 1561
John Walsh is an academic researcher from University of Michigan. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 3, co-authored 3 publications receiving 1540 citations.
Papers
More filters
Journal ArticleDOI
Helicobacter pylori in Peptic Ulcer Disease
Tadataka Yamada,John G. Searle,Dennis J. Ahnen,David H. Aipers,Harry B. Greenberg,Martha Gray,Kent B. Joscelyn,Kent B. McNair,Kent B. Jeffrey,Gordon Kauffman,Daniel K. Podolsky,Wayne A. Ray,Dennis R. Schaberg,Fred E. Silverstein,Michael V. Sivak,Ann L.B. Williams,Robert H. Yolken,Martin J. Blaser,Geron Borsch,Pelayo Correa,Steven J. Czinn,David Forman,David Y. Graham,Jon L. Isenberg,Dennis M. Jensen,Barry J. Marshall,Julie Parsonnet,Walter L. Peterson,Pentti Sipponen,Duane T. Smoot,Andrew H. Soil,Amnon Sonnenberg,Nicholas J. Talley,W. Grant Thompson,Guido N. J. Tytgat,John H. Walsh,T. Ulf Westblom,Kenneth G. Wormsley,Frank A. Hamilton,Addison B. Scoville,Benjamin T. Burton,Leslie Curtis,Jerry M. Elliott,James E. Everhart,John H. Ferguson,Willis R. Foster,William H. Hall,Jay H. Hoofnagle,Leslye D. Johnson,John Walsh,Phillip Gorden,Anthony S. Fauci +51 more
TL;DR: It is concluded that ulcer patients with H. pylori infection require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation with the illness or on recurrence.
Journal ArticleDOI
Progesterone and estrogen are potential mediators of gastric slow-wave dysrhythmias in nausea of pregnancy
TL;DR: Women with nausea of pregnancy exhibit slow-wave rhythm disruption, which may be due to a combination of elevated progesterone and estrogen levels, and similar dysrhythmias are evoked in nonpregnant women by progester one alone or in combination with estradiol in doses that reproduce levels in pregnancy.
Journal ArticleDOI
High-dose interferon alfa-2b and ribavirin in patients previously treated with interferon: Results of a prospective, randomized, controlled trial
TL;DR: The study results and others suggest that standard-dose interferon and ribavirin for 48 weeks should be considered for selected patients who did not respond to previousinterferon therapy.
Journal ArticleDOI
TNF-inhibitors or bisphosphonates in chronic nonbacterial osteomyelitis? - Results of an international retrospective multicenter study.
Anja Schnabel,Mohammed Nashawi,Catriona Anderson,Susanna Felsenstein,Maya Lamoudi,J. Poole-Cowley,E. P. Lindell,Bridget Oates,Peter W Fowlie,John Walsh,T Ellis,Gabriele Hahn,A. A. Goldspink,N Martin,K. Mahmood,Toni Hospach,McCann Lj,Christian M. Hedrich +17 more
TL;DR: In this article , the authors investigated response to non-steroidal anti-inflammatory drugs, corticosteroids, TNF-inhibitors (TNFi) and bisphosphonates.
Journal ArticleDOI
Clinical efficacy and Long-term Immunogenicity of early triple dose COVID-19 mRNA vaccine in cancer patients
Jiaqi Li,Matilda Lee,Siyu Peng,Ainsley Ryan Yan Bin Lee,Ryan Yong Kiat Tay,Cheng E. Chee,C. L. Ho,John Walsh,Yiong Huak Chan,K. B. Tan,Soo-Chin Lee,Louis Yi Ann Chai,Raghav Sundar +12 more